Immuneering Corp(IMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRX Immuneering Corp

交易中 10-02 14:15:05 EDT

2.45

+0.13

+5.60%

最高2.49	最低2.20	成交量54.06万
今开2.26	昨收2.32	日振幅12.47%
总市值7,265万	流通市值4,682万	总股本2,965万
成交额128.15万	换手率2.83%	流通股本1,911万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":2.45,"timestamp":1727892891224,"preClose":2.32,"halted":0,"volume":540602,"delay":0,"floatShares":19110810,"shares":29653355,"eps":-1.907215,"marketStatus":"交易中","marketStatusCode":2,"change":0.13,"latestTime":"10-02 14:15:05 EDT","open":2.26,"high":2.49,"low":2.2006,"amount":1281542.0731465998,"amplitude":0.124741,"askPrice":2.45,"askSize":700,"bidPrice":2.43,"bidSize":800,"shortable":0,"etf":0,"ttmEps":-1.907215,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1727899200000},"adr":0,"listingDate":1627617600000,"adjPreClose":2.32,"preHourTrading":{"tag":"盘前","latestPrice":2.34,"preClose":2.32,"latestTime":"09:25 EDT","volume":17484,"amount":40573.484046,"timestamp":1727875510489},"postHourTrading":{"tag":"盘后","latestPrice":2.3501,"preClose":2.32,"latestTime":"19:56 EDT","volume":4582,"amount":10552.9753,"timestamp":1727826998834},"volumeRatio":0.324792},"requestUrl":"/m/hq/s/IMRX/wiki","defaultTab":"wiki","newsList":[{"id":"2472052579","title":"Immuneering Corporation盘中异动 大幅跳水5.15%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472052579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472052579?lang=zh_cn&edition=full","pubTime":"2024-10-02 21:41","pubTimestamp":1727876490,"startTime":"0","endTime":"0","summary":"北京时间2024年10月02日21时41分，Immuneering Corporation股票出现异动，股价急速跳水5.15%。截至发稿，该股报2.20美元/股，成交量6.8353万股，换手率0.23%，振幅4.74%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.76%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022141309719df2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410022141309719df2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","IMRX","BK4563"],"gpt_icon":0},{"id":"2472334280","title":"Immuneering Corporation盘中异动 下午盘股价大跌5.08%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472334280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472334280?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:44","pubTimestamp":1727718287,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时44分，Immuneering Corporation股票出现异动，股价快速跳水5.08%。截至发稿，该股报2.53美元/股，成交量71.9198万股，换手率2.43%，振幅6.44%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.57%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100101444798e39e5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100101444798e39e5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMRX","BK4539"],"gpt_icon":0},{"id":"2470753508","title":"Immuneering Corporation盘中异动 早盘股价大跌5.10%报2.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470753508","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470753508?lang=zh_cn&edition=full","pubTime":"2024-09-26 22:36","pubTimestamp":1727361414,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日22时36分，Immuneering Corporation股票出现波动，股价急速下跌5.10%。截至发稿，该股报2.79美元/股，成交量112.2万股，换手率3.78%，振幅9.17%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.08%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926223655a1dcc471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926223655a1dcc471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRX","BK4563","BK4139","BK4539"],"gpt_icon":0},{"id":"2470225028","title":"Immuneering Corporation盘中异动 早盘股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470225028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470225028?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:33","pubTimestamp":1727271215,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日21时33分，Immuneering Corporation股票出现波动，股价大幅上涨5.48%。截至发稿，该股报3.08美元/股，成交量22.1958万股，换手率0.75%，振幅2.95%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.27%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925213335ab65e875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240925213335ab65e875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRX","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2469176491","title":"Immuneering Corporation盘中异动 股价大跌5.21%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469176491","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469176491?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:37","pubTimestamp":1727185054,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时37分，Immuneering Corporation股票出现异动，股价急速下跌5.21%。截至发稿，该股报2.72美元/股，成交量16.758万股，换手率0.57%，振幅5.92%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.96%。其相关个股中，Seelos Therapeutics, Inc.、Capricor Therapeutics, Inc.、Wave Life Sciences Ltd.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Capricor Therapeutics, Inc.较为活跃，换手率分别为1052.20%、151.49%、15.98%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Capricor Therapeutics, Inc.、Onconetix, Inc.，振幅分别为41.53%、23.53%、22.28%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213734ab65a588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213734ab65a588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMRX","BK4539"],"gpt_icon":0},{"id":"2469311769","title":"Immuneering Corporation盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469311769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469311769?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:43","pubTimestamp":1727098988,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时43分，Immuneering Corporation股票出现波动，股价快速下挫5.25%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 、Pharmacyte  Biotech, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Black Diamond Therapeutics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为99.08%、30.03%、26.14%，振幅较大的相关个股有Black Diamond Therapeutics, Inc.、Pharmacyte  Biotech, Inc.、天演药业，振幅分别为25.84%、23.46%、17.72%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923214309a1dbecda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923214309a1dbecda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRX","BK4563","BK4539"],"gpt_icon":0},{"id":"2468629286","title":"Immuneering Corporation盘中异动 股价大涨5.37%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468629286","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468629286?lang=zh_cn&edition=full","pubTime":"2024-09-20 21:52","pubTimestamp":1726840333,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日21时52分，Immuneering Corporation股票出现异动，股价急速上涨5.37%。截至发稿，该股报2.55美元/股，成交量31.2377万股，换手率1.05%，振幅7.44%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为1.24%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920215213a1db74dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920215213a1db74dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","BK4139","IMRX"],"gpt_icon":1},{"id":"2468721965","title":"Immuneering Corporation盘中异动 急速拉升10.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468721965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468721965?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:32","pubTimestamp":1726752764,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时32分，Immuneering Corporation股票出现异动，股价大幅拉升10.53%。截至发稿，该股报2.52美元/股，成交量48.4358万股，换手率1.63%，振幅5.97%。Immuneering Corporation股票所在的生物技术行业中，整体涨幅为0.81%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192132449f07f116&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192132449f07f116&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","IMRX","BK4539"],"gpt_icon":1},{"id":"2467779784","title":"Gt Biopharma, Inc.盘中异动 急速下挫5.50%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467779784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467779784?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:33","pubTimestamp":1726238014,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日22时33分，Gt Biopharma, Inc.股票出现波动，股价大幅下挫5.50%。截至发稿，该股报2.06美元/股，成交量522股，换手率0.02%，振幅0.00%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322333598e378c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322333598e378c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRX","BK4563","GTBP","BK4539"],"gpt_icon":0},{"id":"2467779510","title":"Biorestorative Therapies, Inc.盘中异动 早盘股价大涨6.00%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467779510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467779510?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:23","pubTimestamp":1726237406,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日22时23分，Biorestorative Therapies, Inc.股票出现波动，股价快速拉升6.00%。截至发稿，该股报1.59美元/股，成交量2168股，换手率0.03%，振幅1.33%。Biorestorative Therapies, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Biorestorative Therapies, Inc.公司简介：BioRestorative Therapies Inc 是一家总部位于美国的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322232798e378b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322232798e378b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BRTX","IMRX","BK4139","BK4539"],"gpt_icon":0},{"id":"2467791557","title":"木薯科学盘中异动 早盘急速拉升5.10%报29.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467791557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467791557?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:19","pubTimestamp":1726237184,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日22时19分，木薯科学股票出现波动，股价快速拉升5.10%。截至发稿，该股报29.69美元/股，成交量18.2681万股，换手率0.38%，振幅4.57%。木薯科学股票所在的生物技术行业中，整体涨幅为0.03%。公司的候选治疗产品被称为simufilam，这是一种治疗阿尔茨海默病的新药物。该公司目前正在进行两项口服simufilam治疗阿尔茨海默病痴呆患者的随机安慰剂对照3期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322194498e378ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091322194498e378ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4547","BK4563","BK4139","BK4585","IMRX","BK4539","SAVA","BK4007","BK4588"],"gpt_icon":0},{"id":"2467762727","title":"BUZZ-癌症疗法的初步数据良好，Immuneering 跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2467762727","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467762727?lang=zh_cn&edition=full","pubTime":"2024-09-13 22:16","pubTimestamp":1726236971,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月13日 - ** 癌症药物开发商Immuneering公司  股价大涨约72%至2.50美元** 该公司称，其胰腺癌疗法IMM-1-104在一项中期研究中减少或消除了五名受试患者中40%的 (link) 肿瘤 ** 公司预计在年底前至少会报告另一批中期研究患者的数据 ** 尽管盘中股价有所上涨，但今年以来股价仍下跌了约 67","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK4139","IMRX","BK4539"],"gpt_icon":0},{"id":"2467773167","title":"Vincerx Pharma, Inc.盘中异动 快速上涨5.27%报0.747美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467773167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467773167?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:36","pubTimestamp":1726234588,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时36分，Vincerx Pharma, Inc.股票出现异动，股价大幅上涨5.27%。Vincerx Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Vincerx Pharma, Inc.公司简介：Vincerx Pharma Inc 是一家临床阶段生物制药公司，专注于开发和肿瘤学方面的专业知识，以推进新疗法的发展，满足治疗癌症方面尚未得到满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213628a1da324e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240913213628a1da324e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4139","VINC","BK4539","IMRX"],"gpt_icon":0},{"id":"2467735637","title":"Moolec Science Sa盘中异动 早盘快速下挫9.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2467735637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467735637?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:32","pubTimestamp":1726234352,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时32分，Moolec Science Sa股票出现异动，股价急速跳水9.46%。Moolec Science Sa股票所在的生物技术行业中，整体涨幅为0.15%。Moolec Science Sa公司简介：Moolec Science SA 是一家以科学为基础的成分公司，专注于通过分子农业在植物中生产真正的动物蛋白，分子农业是替代蛋白质领域的一种颠覆性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132132329efae48b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409132132329efae48b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4212","BK4139","MLEC","BK4563","IMRX","BK4539"],"gpt_icon":0},{"id":"2467775939","title":"Dbv Technologies盘中异动 早盘急速拉升7.52%报0.790美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467775939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467775939?lang=zh_cn&edition=full","pubTime":"2024-09-13 21:31","pubTimestamp":1726234277,"startTime":"0","endTime":"0","summary":"北京时间2024年09月13日21时31分，Dbv Technologies股票出现异动，股价大幅上涨7.52%。截至发稿，该股报0.790美元/股，成交量1100股，换手率0.00%，振幅0.00%。Dbv Technologies股票所在的生物技术行业中，整体涨幅为0.12%。Dbv Technologies公司简介：DBV Technologies SA 是一家临床阶段的专业生物制药公司，致力于通过开发一个名为 Viaskin 的新型技术平台来改变免疫治疗领域。它的主要候选产品是 Viaskin Peanut，用于治疗花生过敏患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091321311795632170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091321311795632170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DBVT","BK4139","BK4539","BK4563","IMRX"],"gpt_icon":0},{"id":"2467721445","title":"Immuneering(IMRX)盘前涨逾50% 公司胰腺治疗试验积极成果提振","url":"https://stock-news.laohu8.com/highlight/detail?id=2467721445","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467721445?lang=zh_cn&edition=full","pubTime":"2024-09-13 20:08","pubTimestamp":1726229321,"startTime":"0","endTime":"0","summary":"金吾财讯 | Immuneering(IMRX)盘前涨逾50%，截至发稿，报2.13美元。消息面上，药物开发商Immuneering对其候选药物IMM-1-104联合改良吉西他滨/白蛋白结合型紫杉醇药物组合作为胰腺癌一线治疗药物的2a期试验报告了积极数据成果。据悉，该公司表示，该研究迄今为止观察到五名患者中的前两名患者完全或部分缓解，总体初始缓解率为40%，疾病控制率为80%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZjBiNzEwNDA3MTQ3NjM4OTQ3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZjBiNzEwNDA3MTQ3NjM4OTQ3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"279903","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4563","BK4139","IMRX"],"gpt_icon":0},{"id":"2467712510","title":"生物技术公司Immuneering(IMRX.O)股价在盘前交易中上涨35.7%，报1.94美元，此前其癌症疗法在临床试验中显示出良好效果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2467712510","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467712510?lang=zh_cn&edition=full","pubTime":"2024-09-13 16:06","pubTimestamp":1726214769,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1141","BK1576","BK1583","BK4139","BK4539","BK4563","03347","IMRX"],"gpt_icon":0},{"id":"2467176286","title":"受胰腺治疗试验积极成果提振 药物开发商Immuneering(IMRX.US)盘后飙升58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2467176286","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467176286?lang=zh_cn&edition=full","pubTime":"2024-09-13 10:55","pubTimestamp":1726196140,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，药物开发商Immuneering公司(IMRX.US)对其候选药物IMM-1-104联合改良吉西他滨/白蛋白结合型紫杉醇药物组合作为胰腺癌一线治疗药物的2a期试验报告了积极数据成果，该公司股价盘后大涨，截至发稿，已飙升58%。根据一份声明，该公司表示，该研究迄今为止观察到五名患者中的前两名患者完全或部分缓解，总体初始缓解率为40%，疾病控制率为80%。Immuneering表示，预计到今年年底将获得更多数据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1182816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4563","BK4539","IMRX"],"gpt_icon":0},{"id":"2467973714","title":"BUZZ-癌症疗法试验结果喜人，Immuneering 股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2467973714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467973714?lang=zh_cn&edition=full","pubTime":"2024-09-13 05:47","pubTimestamp":1726177629,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月12日 - ** Immuneering  股价在延时交易中上涨46.1%至2.09美元** 药物开发商称，其实验性癌症疗法与化疗相结合，在一项中期研究中对两名胰腺癌患者产生了完全或部分反应** 初步数据显示 IMM-1-104 疗法耐受性良好 - IMRX** 截至上日收盘，股价累计下跌 80.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4563","IMRX","BK4139"],"gpt_icon":0},{"id":"2460003090","title":"Immuneering Corporation盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460003090","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460003090?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:16","pubTimestamp":1724163417,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时16分，Immuneering Corporation股票出现异动，股价大幅跳水5.56%。Immuneering Corporation股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为2530.62%、955.51%、277.08%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、Biomotion Sciences C/Wts Exp 15/08/2029 、泰坦制药，振幅分别为203.45%、78.89%、63.34%。Immuneering Corporation公司简介：Immuneering Corp是一家生物制药公司。该公司拥有独有的计算性疾病抵消技术平台，可实现Immuneering的药物发现项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202216579719950d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408202216579719950d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","BK4139","IMRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuneering.com","stockEarnings":[{"period":"1week","weight":-0.2055},{"period":"1month","weight":1.0901},{"period":"3month","weight":1.0531},{"period":"6month","weight":-0.0128},{"period":"1year","weight":-0.6723},{"period":"ytd","weight":-0.6844}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0311},{"period":"6month","weight":0.1083},{"period":"1year","weight":0.3307},{"period":"ytd","weight":0.1963}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuneering Corporation于2008年在特拉华州注册成立。该公司利用生物信息学开发传统药物发现方法不可能发现的新药。公司目前的候选药物管道专注于治疗传统方法无法解决的疾病。利用其专有的疾病消除技术，公司的目标是发现和开发能够逆转许多相关基因疾病信号的药物。在开展内部计划的同时，该公司还为制药和生物技术公司提供计算生物学服务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.239671},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.009906},{"month":3,"riseRate":0.333333,"avgChangeRate":0.105982},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.203232},{"month":5,"riseRate":0,"avgChangeRate":-0.137963},{"month":6,"riseRate":0.666667,"avgChangeRate":0.145613},{"month":7,"riseRate":0.666667,"avgChangeRate":0.029987},{"month":8,"riseRate":0.25,"avgChangeRate":0.029018},{"month":9,"riseRate":0.75,"avgChangeRate":0.686735},{"month":10,"riseRate":0.25,"avgChangeRate":-0.041253},{"month":11,"riseRate":0,"avgChangeRate":-0.254403},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.139244}],"exchange":"NASDAQ","name":"Immuneering Corp","nameEN":"Immuneering Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuneering Corp(IMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuneering Corp(IMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuneering Corp,IMRX,Immuneering Corp股票,Immuneering Corp股票老虎,Immuneering Corp股票老虎国际,Immuneering Corp行情,Immuneering Corp股票行情,Immuneering Corp股价,Immuneering Corp股市,Immuneering Corp股票价格,Immuneering Corp股票交易,Immuneering Corp股票购买,Immuneering Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuneering Corp(IMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuneering Corp(IMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}